임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

10건 표시

1상모집 예정· HIV -1 Infection
A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
리드: 바이오엔테크
상세 →NCT07698600
1상모집 중· HIV -1 Infection
A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV
리드: 바이오엔테크
상세 →NCT07392372
1상모집 중· Advanced Solid Tumor
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
리드: 바이오엔테크
상세 →NCT06750185
1상모집 중단 (진행 중)· Advanced Malignant Solid Tumor
Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors
리드: 바이오엔테크
상세 →NCT06150183
1상모집 중단 (진행 중)· Malignant Solid Tumor
A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors
협력: 바이오엔테크
상세 →NCT06057038
1상모집 중단 (진행 중)· Non Small Cell Lung Cancer
A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer
협력: 바이오엔테크
상세 →NCT05653752
1상모집 중단 (진행 중)· Genital Herpes Simplex Type 2
A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions
리드: 바이오엔테크
상세 →NCT05432583
1상모집 중· Non-Small Cell Lung Cancer
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
리드: 바이오엔테크
상세 →NCT05142189
1상모집 중· Lymphocytic Leukemia
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
협력: 바이오엔테크, 머크(MSD)
상세 →NCT03219450
1상모집 중단 (진행 중)· Solid Tumor
A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
리드: 바이오엔테크
상세 →NCT04503278

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.